Intratumoral CRH modulates immuno-escape of ovarian cancer cells through FasL regulation.
about
FasL -844T/C and Fas -1377G/A: mutations of pulmonary adenocarcinoma in South China and their clinical significancesDoes somatostatin have a role in the regulation of cortisol secretion in primary pigmented nodular adrenocortical disease (ppnad)? a clinical and in vitro investigation.Metformin limits the adipocyte tumor-promoting effect on ovarian cancer.The impact of stress on tumor growth: peripheral CRF mediates tumor-promoting effects of stress.Immunolocalization of corticotropin-releasing hormone (CRH) and its receptors (CRHR1 and CRHR2) in human endometrial carcinoma: CRHR1 as a potent prognostic factor.Effects of corticotrophin releasing hormone (CRH) on cell viability and differentiation in the human BeWo choriocarcinoma cell line: a potential syncytialisation inducer distinct from cyclic adenosine monophosphate (cAMP)CRF2 signaling is a novel regulator of cellular adhesion and migration in colorectal cancer cells.Diminished expression of CRHR2 in human colon cancer promotes tumor growth and EMT via persistent IL-6/Stat3 signalingThe impact of T-cell immunity on ovarian cancer outcomes.Corticotropin Releasing Factor promotes breast cancer cell motility and invasiveness.FasL gene -844T/C mutation of esophageal cancer in South China and its clinical significance.Tumour-associated antigens: considerations for their use in tumour immunotherapy.Gallium phosphinoarylbisthiolato complexes counteract drug resistance of cancer cells.Estrogen alters the splicing of type 1 corticotropin-releasing hormone receptor in breast cancer cells.Corticotropin-releasing hormone (CRH) is expressed in the human cervical carcinoma cells (HeLa) and upregulates the expression of Fas ligand.FasL gene knock-down therapy enhances the antiglioma immune response.Corticotropin releasing hormone is correlated with tumorigenesis of gastric cancer.CRHR2/Ucn2 signaling is a novel regulator of miR-7/YY1/Fas circuitry contributing to reversal of colorectal cancer cell resistance to Fas-mediated apoptosis.CRH promotes human colon cancer cell proliferation via IL-6/JAK2/STAT3 signaling pathway and VEGF-induced tumor angiogenesis.Murine splenic B cells express corticotropin-releasing hormone receptor 2 that affect their viability during a stress response.
P2860
Q28385359-5857715C-EF21-4322-89E8-088904C456E1Q33569023-212FFDFC-98A1-421D-9BF1-0FCFD1C47886Q34104019-D3B6FDEB-8AE1-4123-A546-AA57B113E7C9Q34208577-EC6E7FE6-A6C6-4889-8224-B20F82DA863DQ34434269-4B10D1B6-B7CF-4B08-9631-4B3B0800FAA1Q34669105-A7B7E107-1A38-4FD8-ABC5-5D94AE469D77Q35048348-9F20C826-FB64-418A-BE33-3A2274A5D0B3Q36174823-437FB433-6D96-4D75-A773-99A3E58BA6F0Q37118142-EA4D54C1-E5CC-4853-B909-74A6D7825E45Q37229340-CB9492B1-C885-4EA4-8528-AAB38638FEC5Q37736549-08F7C11D-FFE8-4068-9D6C-356226F7686CQ37848203-C02F4FCD-297C-49AF-8825-0C21A1D710FCQ39035304-551F3E94-5EF8-4194-BC80-B2BDA5E968B8Q39131186-70E68D9A-8C4C-4F15-B639-C727FBE05189Q39257328-135239BE-4AD0-4972-99E0-B4DC11B07F31Q42425989-B7B997E7-8D2F-4A11-AF66-68646A0F187FQ45776306-98F7D8C3-F7DA-45AC-B029-0C133738D2E8Q47773932-FF0CF4F3-AB20-4C30-8D03-867084A27B58Q48271800-076FC226-2642-4686-8B5F-7A4D9B4EFDB9Q49315731-2B4D4224-6674-4564-B1E3-5371A653D315
P2860
Intratumoral CRH modulates immuno-escape of ovarian cancer cells through FasL regulation.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Intratumoral CRH modulates immuno-escape of ovarian cancer cells through FasL regulation.
@ast
Intratumoral CRH modulates immuno-escape of ovarian cancer cells through FasL regulation.
@en
type
label
Intratumoral CRH modulates immuno-escape of ovarian cancer cells through FasL regulation.
@ast
Intratumoral CRH modulates immuno-escape of ovarian cancer cells through FasL regulation.
@en
prefLabel
Intratumoral CRH modulates immuno-escape of ovarian cancer cells through FasL regulation.
@ast
Intratumoral CRH modulates immuno-escape of ovarian cancer cells through FasL regulation.
@en
P2093
P2860
P356
P1476
Intratumoral CRH modulates immuno-escape of ovarian cancer cells through FasL regulation.
@en
P2093
A Makrigiannakis
E A Paraskevaidis
G P Chrousos
J Sidiropoulos
N Pavlidis
S N Kalantaridou
P2860
P2888
P304
P356
10.1038/SJ.BJC.6603918
P407
P577
2007-07-31T00:00:00Z